How many patents does
Life Sciences Research Partners have?
patents
516
families
61
granted
127
applications
389
US
98
EP
83
WO
45
JP
20
CN
13
KR
10
GB
5
RoW
242
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Life Sciences Research Partners
Top ten assignees appearing on patents
2009 - 2018
| roche | 65 |
| thrombogenics | 31 |
| sanofi | 22 |
| life sciences research partners vz… 🛈 | 3 |
| imcyse | 3 |
| acetylon pharmaceuticals | 2 |
| thromb-x | 2 |
| life science research partners zvw | 1 |
Life Sciences Research Partners
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| novel anti-plgf antibody | 32 | 2005 |
| immunogenic peptides and their use in immune disorders | 31 | 2006 |
| extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor | 28 | 2009 |
| use of vegf and homologues to treat neuron disorders | 25 | 2000 |
| responsiveness to angiogenesis inhibitors | 23 | 2009 |
| inhibition of plgf to treat philadelphia chromosome positive leukemia | 20 | 2008 |
| method for predicting risk of hypertension associated with anti-angiogenesis therapy | 18 | 2011 |
| modified epitopes for boosting cd4+ t-cell responses | 17 | 2012 |
| responsiveness to angiogenesis inhibitors | 17 | 2011 |
| treatment of amyotrophic lateral sclerosis | 16 | 2004 |